Kangji Medical Holdings Limited (FRA:50J)

Market Cap	1.24B
Revenue (ttm)	124.42M
Net Income (ttm)	66.72M
Shares Out	n/a
EPS (ttm)	0.06
PE Ratio	18.55
Forward PE	n/a
Dividend	0.03 (2.98%)
Ex-Dividend Date	May 27, 2025

Volume	n/a
Average Volume	140
Open	1.000
Previous Close	0.995
Day's Range	1.000 - 1.000
52-Week Range	0.645 - 1.020
Beta	n/a
RSI	63.86
Earnings Date	Nov 28, 2025

About Kangji Medical Holdings

Kangji Medical Holdings Limited, an investment holding company, designs, develops, manufactures, and sells minimally invasive surgical instruments and accessories in Mainland China and internationally. The company offers disposable consumables, disposable trocars, disposable electrocoagulation forceps, ultrasonic scalpels, staplers and other disposable products. It provides reusable ultrasonic scalpels soft tissue cutting and hemostatic scalpel, and laparoscopic surgical instrument. In addition, the company offers instruments, including 4K UHD ...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2004
• Employees: 1,007
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 50J

Financial Performance

In 2024, Kangji Medical Holdings's revenue was 1.01 billion, an increase of 8.92% compared to the previous year's 926.02 million. Earnings were 581.44 million, an increase of 15.36%.

Financial numbers in CNY